146 related articles for article (PubMed ID: 34517259)
21. The promotion of nanoparticle delivery to two populations of gastric cancer stem cells by CD133 and CD44 antibodies.
Chen H; Lin J; Shan Y; Zhengmao L
Biomed Pharmacother; 2019 Jul; 115():108857. PubMed ID: 31048191
[TBL] [Abstract][Full Text] [Related]
22. CD133+/CD166+ human gastric adenocarcinoma cells present the properties of neoplastic stem cells and emerge more malignant features.
Ni T; Wang H; Zhan D; Tao L; Lv M; Wang W; Chu Z; Zhou Z; Sunagawa M; Liu Y
Life Sci; 2021 Mar; 269():119021. PubMed ID: 33450261
[TBL] [Abstract][Full Text] [Related]
23. Wnt/β-catenin Signaling Inhibitors suppress the Tumor-initiating properties of a CD44
Kim J; Choi KW; Lee J; Lee J; Lee S; Sun R; Kim J
Int J Biol Sci; 2021; 17(7):1644-1659. PubMed ID: 33994850
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
Harn HJ; Ho LI; Chang JY; Wu CW; Jiang SY; Lee HS; Lee WH
Cancer; 1995 Mar; 75(5):1065-71. PubMed ID: 7531611
[TBL] [Abstract][Full Text] [Related]
25. CD44 and CD133 protein expression might serve as a prognostic factor for early occurrence castration-resistant prostate cancer.
Dwina Y; Zaid LSM; Saraswati M; Rachmadi L; Kekalih A; Rahadiani N; Louisa M; Agustina H; Mochtar CA; Hamid ARAH
Prostate; 2024 Jun; 84(8):738-746. PubMed ID: 38528654
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of CD44v6 in metastases of intestinal and diffuse types of gastric carcinoma.
Castellà EM; Ariza A; Pellicer I; Fernández-Vasalo A; Ojanguren I
J Clin Pathol; 1998 Feb; 51(2):134-7. PubMed ID: 9602687
[TBL] [Abstract][Full Text] [Related]
27. Emerging roles of CD133 in the treatment of gastric cancer, a novel stem cell biomarker and beyond.
Soleimani A; Dadjoo P; Avan A; Soleimanpour S; Rajabian M; Ferns G; Ryzhikov M; Khazaei M; Hassanian SM
Life Sci; 2022 Mar; 293():120050. PubMed ID: 35026215
[TBL] [Abstract][Full Text] [Related]
28. CD44 is functionally crucial for driving lung cancer stem cells metastasis through Wnt/β-catenin-FoxM1-Twist signaling.
Su J; Wu S; Wu H; Li L; Guo T
Mol Carcinog; 2016 Dec; 55(12):1962-1973. PubMed ID: 26621583
[TBL] [Abstract][Full Text] [Related]
29. The Intestinal Stem Cell Marker SMOC2 Is an Independent Prognostic Marker Associated With Better Survival in Gastric Cancer.
Hyun CL; Park SJ; Kim HS; Song HJ; Kim HU; Lee C; Lee DH; Maeng YH; Kim YS; Jang B
Anticancer Res; 2021 Jul; 41(7):3689-3698. PubMed ID: 34230168
[TBL] [Abstract][Full Text] [Related]
30. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
31. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
[TBL] [Abstract][Full Text] [Related]
32. CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach.
Cao X; Cao D; Jin M; Jia Z; Kong F; Ma H; Wang Y; Jiang J
BMC Gastroenterol; 2014 Sep; 14():157. PubMed ID: 25212506
[TBL] [Abstract][Full Text] [Related]
33. Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma.
Choi D; Lee HW; Hur KY; Kim JJ; Park GS; Jang SH; Song YS; Jang KS; Paik SS
World J Gastroenterol; 2009 May; 15(18):2258-64. PubMed ID: 19437567
[TBL] [Abstract][Full Text] [Related]
34. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
[TBL] [Abstract][Full Text] [Related]
35. The study of the tumor stem cell properties of CD133+CD44+ cells in the human lung adenocarcinoma cell line A549.
Zhang HZ; Lin XG; Hua P; Wang M; Ao X; Xiong LH; Wu C; Guo JJ
Cell Mol Biol (Noisy-le-grand); 2010 Sep; 56 Suppl():OL1350-8. PubMed ID: 20937222
[TBL] [Abstract][Full Text] [Related]
36. Less demand on stem cell marker-positive cancer cells may characterize metastasis of colon cancer.
Kaida T; Fujiyama Y; Soeno T; Yokota M; Nakamoto S; Goto T; Watanabe A; Okuno K; Nie Y; Fujino S; Yokota K; Harada H; Tanaka Y; Tanaka T; Yokoi K; Kojo K; Miura H; Yamanashi T; Sato T; Sasaki J; Sangai T; Hiki N; Kumamoto Y; Naitoh T; Yamashita K
PLoS One; 2023; 18(4):e0277395. PubMed ID: 37098074
[TBL] [Abstract][Full Text] [Related]
37. Expressions of Putative Cancer Stem Cell Markers, CD44 and CD133, are Correlated with Pathological Tumour Stage in Gastric Adenocarcinoma.
Duzcu SE; Astarci HM; Tunc N; Boran C
J Coll Physicians Surg Pak; 2021 May; 31(5):553-558. PubMed ID: 34027868
[TBL] [Abstract][Full Text] [Related]
38. CD133+ CD44+ subgroups may be human small intestinal stem cells.
Hou NY; Yang K; Chen T; Chen XZ; Zhang B; Mo XM; Hu JK
Mol Biol Rep; 2011 Feb; 38(2):997-1004. PubMed ID: 20526812
[TBL] [Abstract][Full Text] [Related]
39. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
Hou YC; Chao YJ; Tung HL; Wang HC; Shan YS
Cancer; 2014 Sep; 120(17):2766-77. PubMed ID: 24839953
[TBL] [Abstract][Full Text] [Related]
40. Expression profile of intestinal stem cell and cancer stem cell markers in gastric cancers with submucosal invasion.
Kim HS; Song HJ; Kim HU; Jeong IH; Koh HM; Shin JH; Jang BG
Pathol Res Pract; 2021 Feb; 218():153336. PubMed ID: 33450435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]